GB2117514B - Polyvalent antiglobulin reagent - Google Patents

Polyvalent antiglobulin reagent

Info

Publication number
GB2117514B
GB2117514B GB08308298A GB8308298A GB2117514B GB 2117514 B GB2117514 B GB 2117514B GB 08308298 A GB08308298 A GB 08308298A GB 8308298 A GB8308298 A GB 8308298A GB 2117514 B GB2117514 B GB 2117514B
Authority
GB
United Kingdom
Prior art keywords
polyvalent
antiglobulin reagent
antiglobulin
reagent
polyvalent antiglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08308298A
Other versions
GB8308298D0 (en
GB2117514A (en
Inventor
David John Anstee
Peter Julius Lachmann
Edwin Samuel Lennox
Douglas Voak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EAST ANGLIAN REGIONAL HEALTH
SOUTH WESTERN REGIONAL HEALTH
Original Assignee
EAST ANGLIAN REGIONAL HEALTH
SOUTH WESTERN REGIONAL HEALTH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EAST ANGLIAN REGIONAL HEALTH, SOUTH WESTERN REGIONAL HEALTH filed Critical EAST ANGLIAN REGIONAL HEALTH
Priority to GB08308298A priority Critical patent/GB2117514B/en
Publication of GB8308298D0 publication Critical patent/GB8308298D0/en
Publication of GB2117514A publication Critical patent/GB2117514A/en
Application granted granted Critical
Publication of GB2117514B publication Critical patent/GB2117514B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB08308298A 1982-03-29 1983-03-25 Polyvalent antiglobulin reagent Expired GB2117514B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08308298A GB2117514B (en) 1982-03-29 1983-03-25 Polyvalent antiglobulin reagent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8209208 1982-03-29
GB08308298A GB2117514B (en) 1982-03-29 1983-03-25 Polyvalent antiglobulin reagent

Publications (3)

Publication Number Publication Date
GB8308298D0 GB8308298D0 (en) 1983-05-05
GB2117514A GB2117514A (en) 1983-10-12
GB2117514B true GB2117514B (en) 1985-08-29

Family

ID=26282415

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08308298A Expired GB2117514B (en) 1982-03-29 1983-03-25 Polyvalent antiglobulin reagent

Country Status (1)

Country Link
GB (1) GB2117514B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6175262A (en) * 1984-09-21 1986-04-17 Teijin Ltd Reagent for measuring immunological composite and measurement of composite using the same
JPH07119762B2 (en) * 1986-04-09 1995-12-20 和光純薬工業株式会社 Complement quantification method
SE452065B (en) * 1986-04-11 1987-11-09 Ulf R Nilsson ANTIBODY PREPARATION OUR ANTIBODIES ARE SPECIFIC TO DETERMINANTS IN THE C3 B REGION OF DENATURATED HUMAN C3 AND ITS USE AND MANUFACTURING
US5213963A (en) * 1988-10-12 1993-05-25 Biotest Aktiengesellschaft Procedure for finding and identifying red cell antibodies by means of the solid phase method
ATE98777T1 (en) * 1988-10-12 1994-01-15 Biotest Ag PROCEDURE FOR THE SEARCH AND IDENTIFICATION OF ERYTHROCYTAL ANTIBODIES USING THE SOLID PHASE METHOD.
FR2660437B1 (en) * 1990-03-27 1993-11-19 Lille Ctre Rgl Transfusion Sang METHOD FOR HIGHLIGHTING ERYTHROCYTA AGGLUTINATION FOR BLOOD ACCOUNTING ANALYSIS.
FR2676123B1 (en) * 1991-05-02 1994-06-17 Pasteur Diagnostics AGGLUTINANT COMPLEX AND REAGENT FOR IDENTIFYING ANTIGENS ON CELL WALLS.
FR2687788B1 (en) * 1992-02-24 1994-12-30 Aetsrn MATERIAL FOR THE HIGHLIGHTING IN THE SOLID PHASE OF ANTIGEN-ANTIBODY COMPLEXES BY HEMATIES INDICATING ITS PREPARATION METHOD AND ITS USE.
CA2232344C (en) 1995-10-20 2005-04-05 University Of Nebraska Board Of Regents Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
CN104597259A (en) * 2015-01-04 2015-05-06 许明安 Antihuman-globulin blood matching detection card with different formulas at primary side and secondary side

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes

Also Published As

Publication number Publication date
GB8308298D0 (en) 1983-05-05
GB2117514A (en) 1983-10-12

Similar Documents

Publication Publication Date Title
GB2103791B (en) Carrier bound immunosorbent
GB8530309D0 (en) Antibodies
GB8319605D0 (en) Assay method
GB8300371D0 (en) Immunoassay
GB8333098D0 (en) Alkylxylene sulphonate compounds
GB2117514B (en) Polyvalent antiglobulin reagent
GB2132346B (en) Dilution pipetter
EP0103139A3 (en) Reagent composition for immunoassay and immunoassay using the same
HK90288A (en) Pipetter
EP0089210A3 (en) Reagent for assaying cholinsterase
GB8333622D0 (en) Hydrocarbons
GB8328420D0 (en) Reagent for determining beta-lipoproteins
GB8306617D0 (en) Specific antibody
GB8314332D0 (en) Sulphonation reagent
DE3468278D1 (en) Latex reagent
DE3365451D1 (en) A direct bilirubin assay method
CS291182A1 (en) Zarizeni na zkouseni unavove odolnosti vyztuze prevodovych remenu
GB8319436D0 (en) Reagent
KR840000821Y1 (en) Quantitative pipette
PL243735A1 (en) Pipette
PL243736A1 (en) Pipette
CS485182A1 (en) Zarizeni na vyklapeni ohradovych palet
SU1174068A1 (en) Reagent mixer
AR228001A1 (en) DISPENSING PIPETTE
ZA824695B (en) Carrier bound immunosorbent

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930325